Literature DB >> 27322778

Model Selection and Estimation with Quantal-Response Data in Benchmark Risk Assessment.

Edsel A Peña1, Wensong Wu2, Walter Piegorsch3, Ronald W West4, LingLing An5.   

Abstract

This article describes several approaches for estimating the benchmark dose (BMD) in a risk assessment study with quantal dose-response data and when there are competing model classes for the dose-response function. Strategies involving a two-step approach, a model-averaging approach, a focused-inference approach, and a nonparametric approach based on a PAVA-based estimator of the dose-response function are described and compared. Attention is raised to the perils involved in data "double-dipping" and the need to adjust for the model-selection stage in the estimation procedure. Simulation results are presented comparing the performance of five model selectors and eight BMD estimators. An illustration using a real quantal-response data set from a carcinogenecity study is provided.
© 2016 Society for Risk Analysis.

Entities:  

Keywords:  Focused-inference approach; information measures; model averaging; model selection problem; pooled adjacent violators algorithm (PAVA); quantal-dose response; two-step estimation approach

Mesh:

Substances:

Year:  2016        PMID: 27322778      PMCID: PMC5173468          DOI: 10.1111/risa.12644

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  16 in total

1.  Evaluation of the benchmark dose method for dichotomous data: model dependence and model selection.

Authors:  Salomon Sand; Agneta Falk Filipsson; Katarina Victorin
Journal:  Regul Toxicol Pharmacol       Date:  2002-10       Impact factor: 3.271

2.  Maximum likelihood estimation with binary-data regression models: small-sample and large-sample features.

Authors:  Roland C Deutsch; John M Grego; Brian Habing; Walter W Piegorsch
Journal:  Adv Appl Stat       Date:  2010-02

3.  Variance Estimation in a Model with Gaussian Sub-Models.

Authors:  Vanja M Dukić; Edsel A Peña
Journal:  J Am Stat Assoc       Date:  2005-03-01       Impact factor: 5.033

4.  The Impact of Model Uncertainty on Benchmark Dose Estimation.

Authors:  R Webster West; Walter W Piegorsch; Edsel A Peña; Lingling An; Wensong Wu; Alissa A Wickens; Hui Xiong; Wenhai Chen
Journal:  Environmetrics       Date:  2012-12       Impact factor: 1.900

5.  Potential uncertainty reduction in model-averaged benchmark dose estimates informed by an additional dose study.

Authors:  Kan Shao; Mitchell J Small
Journal:  Risk Anal       Date:  2011-03-09       Impact factor: 4.000

6.  Confidence limits on one-stage model parameters in benchmark risk assessment.

Authors:  Brooke E Buckley; Walter W Piegorsch; R Webster West
Journal:  Environ Ecol Stat       Date:  2009-03-01       Impact factor: 1.119

7.  Toxicity value for 3-monochloropropane-1,2-diol using a benchmark dose methodology.

Authors:  Myungsil Hwang; Eunkyung Yoon; Jayoung Kim; Dong Deuk Jang; Tae Moo Yoo
Journal:  Regul Toxicol Pharmacol       Date:  2008-12-25       Impact factor: 3.271

8.  Nonparametric estimation of benchmark doses in environmental risk assessment.

Authors:  Walter W Piegorsch; Hui Xiong; Rabi N Bhattacharya; Lizhen Lin
Journal:  Environmetrics       Date:  2012-12-01       Impact factor: 1.900

9.  Information-theoretic model-averaged benchmark dose analysis in environmental risk assessment.

Authors:  Walter W Piegorsch; Lingling An; Alissa A Wickens; R Webster West; Edsel A Peña; Wensong Wu
Journal:  Environmetrics       Date:  2013-05-01       Impact factor: 1.900

Review 10.  Biostatistical issues in the design and analysis of animal carcinogenicity experiments.

Authors:  C J Portier
Journal:  Environ Health Perspect       Date:  1994-01       Impact factor: 9.031

View more
  1 in total

1.  Benchmark dose risk analysis with mixed-factor quantal data in environmental risk assessment.

Authors:  Maria A Sans-Fuentes; Walter W Piegorsch
Journal:  Environmetrics       Date:  2021-03-09       Impact factor: 1.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.